We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M Turnover 41.45%
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+5.95%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$114M
AUM Growth
+$5.96M
Cap. Flow
+$1.42M
Cap. Flow %
1.24%
Top 10 Hldgs %
48.81%
Holding
78
New
3
Increased
13
Reduced
18
Closed
7
Avg Time Held
1.5 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1.7 years

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.22M
2
CSCO icon
Cisco
CSCO
+$2.07M
3
PFE icon
Pfizer
PFE
+$1.03M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$991K
5
MCK icon
McKesson
MCK
+$851K

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.97%
2 Consumer Discretionary 16.41%
3 Healthcare 15.86%
4 Communication Services 14.66%
5 Technology 12.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BABA icon
1
Alibaba
BABA
$276B
$6.57M 5.75%
46,595
+6,299
+16% +$778K
2015 Q4
6 quarters
DXJ icon
2
WisdomTree Japan Hedged Equity Fund
DXJ
$2.35B
$6.33M 5.55%
365,208
+155,841
+74% +$2.66M
2013 Q4
14 quarters
GOOGL icon
3
Alphabet (Google) Class A
GOOGL
$4.27T
$6.3M 5.52%
135,580
-3,680
-3% -$172K
2015 Q4
6 quarters
IBB icon
4
iShares Biotechnology ETF
IBB
$10.7B
$6.02M 5.28%
58,275
-3,468
-6% -$342K
2016 Q2
4 quarters
AAPL icon
5
Apple
AAPL
$4.99T
$5.89M 5.16%
163,480
-6,180
-4% -$228K
2013 Q4
14 quarters
PRAH
6
DELISTED
PRA Health Sciences, Inc.
PRAH
$5.49M 4.81%
+73,180
New +$5.07M
2017 Q2
0 quarters
COO icon
7
Cooper Companies
COO
$10.9B
$5.31M 4.65%
88,696
-5,684
-6% -$309K
2016 Q2
4 quarters
JD icon
8
JD.com
JD
$37.1B
$5.08M 4.45%
129,466
+25,704
+25% +$970K
2015 Q4
6 quarters
GWX icon
9
State Street SPDR S&P International Small Cap ETF
GWX
$901M
$4.41M 3.86%
132,120
+46,350
+54% +$1.51M
2016 Q2
4 quarters
T icon
10
AT&T
T
$160B
$4.31M 3.77%
151,133
+2,960
+2% +$87.3K
2013 Q4
14 quarters
CVS icon
11
CVS Health
CVS
$118B
$4.21M 3.69%
52,273
-2,108
-4% -$166K
2016 Q4
2 quarters
AMZN icon
12
Amazon
AMZN
$2.75T
$4M 3.51%
82,680
+1,580
+2% +$75.4K
2013 Q4
14 quarters
CSCO icon
13
Cisco
CSCO
$431B
$3.59M 3.14%
114,646
-63,470
-36% -$2.07M
2014 Q1
13 quarters
BIDU icon
14
Baidu
BIDU
$28.1B
$3.41M 2.99%
19,065
+3,868
+25% +$701K
2015 Q4
6 quarters
FXI icon
15
iShares China Large-Cap ETF
FXI
$3.94B
$3.32M 2.91%
83,602
-7,895
-9% -$309K
2013 Q4
14 quarters
SLB icon
16
SLB Ltd
SLB
$71.3B
$2.75M 2.41%
41,743
-1,989
-5% -$143K
2013 Q4
14 quarters
GE icon
17
GE Aerospace
GE
$323B
$2.71M 2.37%
20,916
-575
-3% -$78.8K
2013 Q4
14 quarters
GLD icon
18
SPDR Gold Trust
GLD
$141B
$2.29M 2%
19,361
+95
+0.5% +$11.4K
2013 Q4
14 quarters
GM icon
19
General Motors
GM
$73.6B
$2.07M 1.82%
59,306
-3,208
-5% -$109K
2016 Q4
2 quarters
WDC icon
20
Western Digital
WDC
$132B
$1.92M 1.68%
28,669
-604
-2% -$40.1K
2016 Q2
4 quarters
WFC icon
21
Wells Fargo
WFC
$248B
$1.59M 1.4%
28,762
+4,630
+19% +$248K
2016 Q2
4 quarters
EWJ icon
22
iShares MSCI Japan ETF
EWJ
$23.2B
$1.59M 1.39%
29,563
– –
2013 Q4
14 quarters
GOOG icon
23
Alphabet (Google) Class C
GOOG
$4.22T
$1.55M 1.36%
34,060
-560
-2% -$25.6K
2016 Q2
4 quarters
DUK icon
24
Duke Energy
DUK
$92.9B
$1.4M 1.22%
16,687
+10
+0.1% +$841
2016 Q4
2 quarters
JNJ icon
25
Johnson & Johnson
JNJ
$611B
$1.3M 1.14%
9,799
-511
-5% -$65.2K
2013 Q4
14 quarters

Similar funds

Bellecapital's Q2 2017 Portfolio in Review

As of Q2 2017, Bellecapital held 78 positions worth $114M, up 5.5% from $108M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Bellecapital's Q2 2017 filing shows 3 new, 13 increased, 18 reduced and 7 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M. The largest sale was Procter & Gamble, an estimated $3.22M.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bellecapital's largest Q2 2017 buy was PRA Health Sciences, Inc.: 73,180 shares worth $5.49M.
  • Bellecapital added most to WisdomTree Japan Hedged Equity Fund in Q2 2017, an estimated $2.66M increase.
  • Bellecapital's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $3.22M.
  • Bellecapital fully exited Pfizer in Q2 2017, selling an estimated $1.03M.
  • Bellecapital's ten largest holdings make up 49% of its $114M portfolio in Q2 2017.
  • Bellecapital opened 3 new positions and closed 7 in Q2 2017.
  • Bellecapital's portfolio value rose 5.5% quarter-over-quarter to $114M.

Based on Bellecapital's 13F filing for Q2 2017, filed 26 Jul 2017.